
Study Period | 2019 - 2030 |
Market Size (2025) | USD 1.56 Billion |
Market Size (2030) | USD 1.96 Billion |
CAGR (2025 - 2030) | 4.70 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players![]() *Disclaimer: Major Players sorted in no particular order |
Ophthalmic Lasers Market Analysis
The Ophthalmic Lasers Market size is estimated at USD 1.56 billion in 2025, and is expected to reach USD 1.96 billion by 2030, at a CAGR of 4.7% during the forecast period (2025-2030).
The ophthalmic lasers industry is experiencing significant transformation driven by demographic shifts and changing healthcare needs globally. According to the World Economic Forum's 2022 report, approximately half of the world's population is predicted to be short-sighted by 2050, representing a dramatic rise in potential treatment requirements. This demographic shift is particularly notable in its gender distribution, with studies showing women are 24% more likely than men to develop myopia as children, though 12% less likely as adults. The financial implications of untreated vision disorders are substantial, with uncorrected myopia alone creating a global economic burden of USD 244 billion, while presbyopia adds another USD 25.4 billion to this figure.
Technological advancements in eye lasers systems are revolutionizing treatment approaches and expanding the scope of ophthalmic procedures. The integration of artificial intelligence and machine learning algorithms in laser systems is enhancing treatment precision and predictability. Femtosecond lasers are gaining particular prominence, offering faster and more precise treatments while significantly improving patient outcomes. These technological innovations are enabling non-invasive treatments for various conditions, from refractive errors to complex retinal disorders, while minimizing collateral tissue damage and improving recovery times.
Strategic industry initiatives and product innovations are reshaping the competitive landscape. In April 2023, Nova Eye Medical's launch of the next-generation canaloplasty device, iTrack Advance, in European and Asia-Pacific markets exemplifies the industry's focus on innovation. This device's proprietary illuminated fiber optic tip represents a significant advancement in surgical precision and monitoring capabilities. The industry is witnessing increased collaboration between technology providers and healthcare institutions, fostering the development of more sophisticated and integrated ophthalmology equipment solutions.
The market is experiencing a shift toward personalized treatment approaches and value-based care models. Subthreshold laser technologies have expanded dramatically, offering new possibilities for treating various ophthalmic conditions while minimizing side effects. The World Health Organization reports that at least 2.2 billion people globally have near or distant vision impairment, with approximately one billion cases being preventable or yet to be addressed. This substantial untreated population represents both a significant market opportunity and a challenge for healthcare providers to develop more accessible and efficient treatment solutions using eye treatment laser technologies.
Ophthalmic Lasers Market Trends
High Prevalence of Ophthalmic Disorders
The rising burden of ophthalmic disorders globally has created an urgent need for advanced treatment solutions, particularly laser eye surgery interventions. According to the World Health Organization's 2021 data, approximately 2.2 billion people worldwide have vision impairment or blindness, of whom at least 1 billion have preventable vision impairment. The breakdown of these cases reveals significant numbers across various conditions: 123.7 million people affected by unresolved refractive error, 65.2 million by cataracts, 6.9 million by glaucoma, 4.2 million by corneal opacities, and 3 million by diabetic retinopathy. These statistics underscore the substantial patient population requiring femtosecond laser and retinal laser interventions.
The financial implications of untreated vision impairment further emphasize the critical need for effective treatment options. The annual global costs of productivity losses associated with uncorrected myopia and presbyopia alone are estimated at USD 244 billion and USD 25.4 billion, respectively. Additionally, the demographic shift towards an aging population is expected to significantly impact the prevalence of eye diseases, with the proportion of the global population aged 60 and above projected to nearly double from 12.0% to 22.0% between 2015 and 2050. This aging trend, combined with the increasing incidence of lifestyle-related eye disorders, is creating a sustained demand for laser eye care treatments.
Increasing Regulatory Approvals for Ophthalmic Lasers
The ophthalmic laser market is experiencing significant momentum driven by increasing regulatory approvals for innovative laser technologies and treatments. In 2023, regulatory bodies worldwide have shown increased support for advanced ophthalmic laser systems, as evidenced by notable approvals such as BELKIN Vision receiving the CE mark for its Eagle laser under the Medical Device Regulation (MDR), making it the first automated non-contact laser glaucoma treatment available in Europe. These approvals are complemented by comprehensive regulatory frameworks that ensure both the safety and efficacy of laser treatments while promoting innovation in the field.
The regulatory landscape has evolved to accommodate newer technologies while maintaining stringent safety standards. For instance, the FDA's recent guidance on conveying potential risks with Laser-Assisted In Situ Keratomileusis (LASIK) laser products in labeling demonstrates the regulatory bodies' commitment to patient safety while supporting technological advancement. This guidance includes recommendations for comprehensive labeling information covering general surgical procedures, indications for use, benefits, alternatives, contraindications, warnings and precautions, and clinical study information. Such regulatory support has enabled companies like Iridex Corporation to expand their market presence, as evidenced by their recent clearance to market the Cyclo G6 platform in China through the National Medical Products Administration (NMPA).
Increasing Initiatives to Control Visual Impairments
Global efforts to address visual impairments have intensified through various initiatives and programs aimed at prevention and treatment. A significant milestone was achieved when governments adopted a new resolution at the United Nations General Assembly, committing to greater efforts to make eye care services an integral part of universal health coverage. This commitment has been reinforced by various awareness campaigns and programs, such as World Sight Day, an annual event held on the second Thursday of October, which focuses global attention on vision impairment and blindness under the theme "Love Your Eyes."
The private sector has also demonstrated substantial commitment to visual impairment control through various programs and investments. For instance, the Novartis Excellence in Ophthalmology Vision Awards (XOVA) program has made available up to USD 500,000 annually to fund up to 10 awards for programs working to deliver sustainable, improved eye care to help reduce the burden of blindness worldwide. Similarly, CooperVision's investment of USD 40,000 to support the International Agency for the Prevention of Blindness (IAPB) 2022 Focus on School Eye Health Initiative demonstrates the industry's commitment to addressing visual impairment at early stages. These initiatives, combined with public-private partnerships and awareness campaigns, are creating a more robust ecosystem for visual impairment prevention and treatment.
Segment Analysis: By Product
Femtosecond Lasers Segment in Ophthalmic Lasers Market
The femtosecond laser segment continues to dominate the global ophthalmic lasers market, holding approximately 35% of the market share in 2024. This significant market position is attributed to the segment's superior precision and reliability in various ophthalmic procedures, particularly in cataract and refractive surgeries. The technology's ability to create precise and reproducible corneal flaps, along with its effectiveness in performing capsulotomies and other intricate procedures, has made it the preferred choice among ophthalmologists worldwide. Major market players like LENSAR and Carl Zeiss Meditec AG have been instrumental in advancing femtosecond laser technology, introducing innovations that enhance surgical outcomes and patient satisfaction.

Excimer Lasers Segment in Ophthalmic Lasers Market
The Excimer Lasers segment is projected to experience the fastest growth in the ophthalmic lasers market during the forecast period 2024-2029, with an expected growth rate of approximately 6%. This remarkable growth is driven by the increasing prevalence of refractive errors globally and the rising demand for laser-assisted in situ keratomileusis (LASIK) procedures. The segment's growth is further supported by technological advancements in excimer laser systems, which have improved treatment precision and reduced recovery time. Recent developments by key manufacturers have focused on enhancing the accuracy and safety profiles of these systems, making them more attractive to both practitioners and patients seeking vision correction solutions.
Remaining Segments in Ophthalmic Lasers Market by Product
The remaining segments in the ophthalmic lasers market include ophthalmic YAG laser, Diode Lasers, and Other Products, each serving specific therapeutic needs in ophthalmology. Ophthalmic YAG laser systems have established themselves as essential tools for posterior capsulotomy and peripheral iridotomy procedures, while Diode Lasers are particularly valued for their versatility in treating glaucoma and retinal conditions. The Other Products category encompasses emerging laser technologies and specialized systems that address specific ophthalmic conditions. These segments collectively contribute to the market's diversity and provide practitioners with a comprehensive range of treatment options for various eye disorders.
Segment Analysis: By Application
Cataract Removal Segment in Ophthalmic Lasers Market
The cataract removal segment dominates the ophthalmic lasers market, commanding approximately 32% of the market share in 2024. This segment's leadership position is primarily driven by the increasing prevalence of cataracts globally, particularly among the aging population. The segment's growth is further bolstered by technological advancements in femtosecond laser and other innovative laser technologies specifically designed for cataract procedures. The integration of artificial intelligence and machine learning in cataract surgery systems has enhanced precision and improved surgical outcomes. Additionally, the segment is experiencing the fastest growth rate in the market, driven by increasing adoption of premium intraocular lenses and bladeless laser procedures. The development of next-generation laser systems with enhanced safety features and improved surgical precision has also contributed to the segment's robust performance.
Remaining Segments in Ophthalmic Lasers Market by Application
The ophthalmic lasers market encompasses several other significant application segments, including refractive surgery laser corrections, glaucoma treatment, diabetic retinopathy, and other specialized applications. The refractive error corrections segment holds substantial market share due to the rising prevalence of myopia and other vision disorders, particularly among younger populations. The glaucoma treatment segment maintains its importance through innovative laser trabeculoplasty techniques and advanced treatment options. The diabetic retinopathy segment continues to grow with the increasing prevalence of diabetes globally and the subsequent rise in related eye complications. Other applications include treatments for age-related macular degeneration, retinal disorders, and various specialized ophthalmic conditions, contributing to the market's diversity and comprehensive coverage of eye health needs.
Segment Analysis: By End User
Hospitals Segment in Ophthalmic Lasers Market
The hospitals segment continues to dominate the global ophthalmic lasers market, accounting for approximately 54% of the total market share in 2024. This significant market position is attributed to hospitals' ability to handle complex ophthalmic procedures and their comprehensive infrastructure for both diagnosis and treatment. Well-equipped hospitals are consistently preferred over other facilities for ophthalmic surgeries, particularly in cases involving medical complications or emergency procedures. The segment's strength is further reinforced by hospitals' capacity to establish beneficial trade contracts and agreements with manufacturers and distributors, enabling them to achieve economies of scale through bulk purchasing of equipment. Additionally, hospitals typically maintain strong clinical teams and essential equipment such as corneal topography systems, which are crucial for successful ophthalmic procedures.
Eye Clinics Segment in Ophthalmic Lasers Market
The eye clinics segment is projected to exhibit the fastest growth in the ophthalmic lasers market during the forecast period 2024-2029, with an expected growth rate of approximately 6%. This accelerated growth is primarily driven by the segment's ability to provide specialized care without the typical waiting lists or appointment delays associated with larger healthcare facilities. Eye clinics are increasingly preferred for their focused approach to ophthalmic procedures, offering more comfortable surgical environments compared to traditional hospital operating rooms. These specialized facilities typically provide faster procedures in more relaxed surroundings, contributing to enhanced patient experience. The growth is further supported by strategic partnerships between eye clinics and manufacturing companies, enabling access to cutting-edge ophthalmic laser technologies and specialized treatment options.
Remaining Segments in End User Market Segmentation
The other end users segment, which includes ambulatory surgery centers (ASCs) and specialty centers, plays a vital role in the ophthalmic lasers market by providing specialized and focused care options. These facilities are particularly notable for their emphasis on same-day surgical care, requiring similar infrastructure to hospital operating rooms but with a more streamlined approach to patient care. Ambulatory surgery centers are gaining prominence due to their ability to utilize fewer resources, reduce costs, and limit patient exposure to hospital-acquired infections. These facilities are particularly effective in handling various ophthalmic conditions, offering the benefits of modern healthcare delivery while maintaining high standards of care and patient satisfaction.
Ophthalmic Lasers Market Geography Segment Analysis
Ophthalmic Lasers Market in North America
The North American ophthalmic lasers market demonstrates robust growth driven by advanced healthcare infrastructure, high adoption of innovative medical technologies, and an increasing prevalence of eye disorders. The United States leads the regional market, followed by Canada and Mexico, benefiting from well-established healthcare systems and increasing regulatory approvals for ophthalmic laser technologies. The region's market is characterized by the presence of major market players, extensive research and development activities, and growing awareness about vision impairment treatments.

Ophthalmic Lasers Market in United States
The United States dominates the North American ophthalmic lasers market with approximately 79% market share in the region. The country's market leadership is attributed to factors such as a rising geriatric population, increasing prevalence of ophthalmic disorders, and technological advancements in ophthalmology equipment. The growing inclination toward ophthalmologic treatments, increasing innovations in ophthalmic laser devices, high adoption rate of new healthcare technologies, and comprehensive insurance coverage for ophthalmic procedures contribute to market growth. The presence of leading market players and their focus on research and development activities further strengthens the country's position in the regional market.
Ophthalmic Lasers Market in Canada
Canada emerges as the fastest-growing market in North America, with a projected CAGR of approximately 6% during 2024-2029. The country's market growth is driven by the large prevalence of vision impairment cases, increasing initiatives focusing on vision disorders, and product approvals by regulatory authorities. The Canadian healthcare system's strong focus on vision care, coupled with various initiatives aimed at providing vision therapy to affected populations, contributes to market expansion. The rising innovations in ocular lasers technologies and increasing approvals from Canadian health regulatory agencies further boost market growth.
Ophthalmic Lasers Market in Europe
The European ophthalmic lasers market showcases significant growth potential, supported by advanced healthcare infrastructure and increasing adoption of innovative medical technologies. Germany leads the regional market, followed by the United Kingdom, France, Italy, and Spain. The region benefits from strong healthcare systems, extensive research activities, and growing awareness about vision impairment treatments. The presence of major market players and their focus on technological innovations contributes to market expansion.
Ophthalmic Lasers Market in Germany
Germany maintains its position as the largest market in Europe with approximately 20% market share in the region. The country's market leadership is attributed to substantial investments in healthcare infrastructure, an increasing burden of ophthalmic diseases, and a growing geriatric population. The presence of key market players, coupled with various funding activities by the government focusing on ophthalmic lasers, strengthens Germany's position. The country's robust healthcare system and emphasis on technological advancement in medical devices contribute to market growth.
Ophthalmic Lasers Market in France
France demonstrates the highest growth potential in Europe, with a projected CAGR of approximately 7% during 2024-2029. The country's market growth is driven by the significant population affected by vision impairment problems and various product innovations by key market players. The French healthcare system's strong focus on vision care, coupled with increasing adoption of advanced eye surgery laser technologies, contributes to market expansion. The presence of innovative products and growing research studies focusing on ophthalmic laser therapies further accelerate market growth.
Ophthalmic Lasers Market in Asia-Pacific
The Asia-Pacific ophthalmic lasers market exhibits strong growth potential, driven by increasing healthcare expenditure, growing awareness about eye disorders, and improving healthcare infrastructure. The region encompasses key markets including China, Japan, India, Australia, and South Korea, each contributing significantly to market growth. The large patient population, rising adoption of advanced medical technologies, and increasing healthcare investments characterize the regional market dynamics.
Ophthalmic Lasers Market in China
China emerges as the dominant market in the Asia-Pacific region, leading both in terms of market size and growth rate. The country's market leadership is attributed to its large population base, increasing prevalence of eye-related diseases, and substantial investments in healthcare infrastructure. The growing adoption of advanced medical technologies, coupled with rising healthcare expenditure and improving reimbursement policies, strengthens China's position in the regional market.
Ophthalmic Lasers Market in Japan
Japan demonstrates significant growth potential in the Asia-Pacific region, driven by its aging population and advanced healthcare infrastructure. The country's market growth is supported by increasing cases of eye disorders, technological advancements in the field of ophthalmology, and rising healthcare investments. The presence of key market players and their focus on innovation contributes to market expansion.
Ophthalmic Lasers Market in Middle East and Africa
The Middle East and Africa ophthalmic lasers market shows steady growth potential, characterized by improving healthcare infrastructure and increasing awareness about eye disorders. The region encompasses key markets including GCC countries and South Africa, with GCC emerging as both the largest and fastest-growing market. The increasing healthcare investments, growing medical tourism, and rising prevalence of ophthalmic disorders contribute to market expansion in the region.
Ophthalmic Lasers Market in South America
The South American ophthalmic lasers market demonstrates promising growth potential, driven by improving healthcare infrastructure and increasing awareness about eye disorders. The region includes key markets such as Brazil and Argentina, with Brazil emerging as both the largest and fastest-growing market. The rising prevalence of eye diseases, growing healthcare expenditure, and increasing adoption of advanced medical technologies contribute to market expansion in the region.
Ophthalmic Lasers Industry Overview
Top Companies in Ophthalmic Lasers Market
The ophthalmic lasers market is characterized by the strong presence of established players like Novartis AG (Alcon Laboratories), Johnson & Johnson Surgical Vision, Bausch Health Companies, Topcon Corporation, and NIDEK Co. Ltd. These ophthalmic laser companies are actively pursuing product innovation through the development of advanced laser technologies, particularly in the femtosecond and excimer laser segments. The industry witnesses continuous strategic collaborations and partnerships to enhance technological capabilities and expand geographical reach, as exemplified by recent partnerships between Topcon and Iridex Corporation. Companies are increasingly focusing on integrating artificial intelligence and machine learning capabilities into their laser systems to improve surgical outcomes. Market leaders are also emphasizing operational agility through investments in research and development facilities across multiple regions, while simultaneously expanding their distribution networks to penetrate emerging markets.
Consolidated Market with Strong Regional Players
The ophthalmic lasers market demonstrates a moderate to high degree of competition, characterized by a mix of global conglomerates and specialized medical device manufacturers. The market structure shows a notable level of consolidation in developed regions like North America and Europe, where major players have established strong distribution networks and brand presence. These companies leverage their diverse product portfolios and extensive research capabilities to maintain their competitive positions. The industry has witnessed significant merger and acquisition activities, particularly focused on acquiring innovative technologies and expanding geographical presence.
The competitive dynamics are further shaped by the presence of regional players who have carved out strong positions in their respective markets, particularly in the Asia-Pacific regions. These companies compete through specialized product offerings and local market expertise, often forming strategic partnerships with global players to enhance their technological capabilities. The market also sees the emergence of new entrants, although high entry barriers in terms of regulatory requirements, technological expertise, and established distribution channels limit their immediate impact on market dynamics.
Innovation and Market Access Drive Success
Success in the ophthalmic lasers market increasingly depends on companies' ability to innovate while maintaining cost competitiveness. Incumbent players need to focus on continuous technological advancement, particularly in areas like precision and safety features, while simultaneously expanding their service and support networks. The integration of advanced technologies like artificial intelligence and automation capabilities into laser systems represents a critical differentiation factor. Companies must also develop comprehensive training programs for healthcare professionals and maintain strong relationships with key opinion leaders in the ophthalmology field.
For contenders looking to gain market share, the focus should be on developing specialized solutions for specific ophthalmic conditions while building strategic partnerships with established healthcare providers. The relatively low threat of substitution products provides stability, but companies must navigate complex regulatory requirements across different regions. Success also depends on understanding and adapting to regional healthcare systems and reimbursement policies. Market players need to consider the increasing concentration of end-users in large healthcare facilities and adapt their distribution and service models accordingly, while maintaining flexibility to serve smaller specialized clinics. The integration of ophthalmology equipment and eye surgery laser technologies is crucial for addressing diverse market needs.
Ophthalmic Lasers Market Leaders
-
Alcon Laboratories Inc. (Novartis AG)
-
IRIDEX Corporation
-
Johnson & Johnson Surgical Vision Inc.
-
Bausch & Lomb Incorporated (Bausch Health Companies Inc.)
-
Lumenis
- *Disclaimer: Major Players sorted in no particular order

Ophthalmic Lasers Market News
- In June 2022, Iridex Corporation received regulatory clearance to market and sell its Cyclo G6 platform for the treatment of glaucoma diseases in China by its National Medical Products Administration (NMPA). The Cyclo G6 system utilizes the company's MP3 Probe to deliver its MicroPulse TLT, providing non-incisional IOP control in a quick, effective, and safe procedure.
- In April 2022, Lumibird Group launched the Capsulo Nd: YAG laser. The device is designed to be a fully integrated, versatile laser platform, enabling efficient and accurate capsulotomy and iridotomy treatments.
Ophthalmic Lasers Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 High Prevalence of Ophthalmic Disorders
- 4.2.2 Increasing Regulatory Approvals for Ophthalmic Lasers
- 4.2.3 Increasing Initiatives to Control Visual Impairments
-
4.3 Market Restraints
- 4.3.1 Huge Cost Associated with Ophthalmic Laser Therapies
- 4.3.2 Reduced Availability of Skilled Practitioners
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Product
- 5.1.1 Diode Lasers
- 5.1.2 Femtosecond Lasers
- 5.1.3 Excimer Lasers
- 5.1.4 Nd:YAG Lasers
- 5.1.5 Other Products
-
5.2 By Application
- 5.2.1 Glaucoma
- 5.2.2 Cataract Removal
- 5.2.3 Refractive Error Corrections
- 5.2.4 Diabetic Retinopathy
- 5.2.5 Other Applications
-
5.3 By End User
- 5.3.1 Hospitals
- 5.3.2 Eye Clinics
- 5.3.3 Other End Users
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Novartis AG (Alcon Laboratories Inc)
- 6.1.2 Johnson & Johnson Surgical Vision Inc.
- 6.1.3 Bausch Health Companies Inc. (Bausch & Lomb Incorporated )
- 6.1.4 Topcon Corporation
- 6.1.5 IRIDEX Corporation
- 6.1.6 LIGHTMED
- 6.1.7 Ziemer Opthalmic Systems AG
- 6.1.8 SCHWIND eye-tech-solutions
- 6.1.9 Lumenis
- 6.1.10 Lumibird Group (Quantel Medical)
- 6.1.11 Carl Zeiss Meditec AG
- 6.1.12 NIDEK Co., Ltd.
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Ophthalmic Lasers Industry Segmentation
As per the scope, the ophthalmic laser is a medical device used to target ophthalmic cells in order to operate ophthalmic disorders. Ophthalmic lasers are used for treating a wide range of eye problems. They are used in various ophthalmic disorder procedures, including cataract surgery, laser trabeculoplasty, retinal photocoagulation, and laser iridotomy. Significant accuracy, low-cost, safe procedure, and convenient ophthalmic tools have increased the demand for ophthalmic lasers in the market. The ophthalmic lasers market is segmented by product (diode lasers, femtosecond lasers, excimer lasers, Nd: YAG Lasers, and other products), application (glaucoma, cataract removal, refractive error corrections, diabetic retinopathy, and other applications), end user (hospitals, eye clinics, and other end users) and geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers values in (in USD million) for the above segments.
By Product | Diode Lasers | ||
Femtosecond Lasers | |||
Excimer Lasers | |||
Nd:YAG Lasers | |||
Other Products | |||
By Application | Glaucoma | ||
Cataract Removal | |||
Refractive Error Corrections | |||
Diabetic Retinopathy | |||
Other Applications | |||
By End User | Hospitals | ||
Eye Clinics | |||
Other End Users | |||
Geography | North America | United States | |
Canada | |||
Mexico | |||
Europe | Germany | ||
United Kingdom | |||
France | |||
Italy | |||
Spain | |||
Rest of Europe | |||
Asia-Pacific | China | ||
Japan | |||
India | |||
Australia | |||
South Korea | |||
Rest of Asia-Pacific | |||
Middle East and Africa | GCC | ||
South Africa | |||
Rest of Middle East and Africa | |||
South America | Brazil | ||
Argentina | |||
Rest of South America |
Ophthalmic Lasers Market Research FAQs
How big is the Ophthalmic Lasers Market?
The Ophthalmic Lasers Market size is expected to reach USD 1.56 billion in 2025 and grow at a CAGR of 4.70% to reach USD 1.96 billion by 2030.
What is the current Ophthalmic Lasers Market size?
In 2025, the Ophthalmic Lasers Market size is expected to reach USD 1.56 billion.
Who are the key players in Ophthalmic Lasers Market?
Alcon Laboratories Inc. (Novartis AG), IRIDEX Corporation, Johnson & Johnson Surgical Vision Inc., Bausch & Lomb Incorporated (Bausch Health Companies Inc.) and Lumenis are the major companies operating in the Ophthalmic Lasers Market.
Which is the fastest growing region in Ophthalmic Lasers Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).
Which region has the biggest share in Ophthalmic Lasers Market?
In 2025, the North America accounts for the largest market share in Ophthalmic Lasers Market.
What years does this Ophthalmic Lasers Market cover, and what was the market size in 2024?
In 2024, the Ophthalmic Lasers Market size was estimated at USD 1.49 billion. The report covers the Ophthalmic Lasers Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Ophthalmic Lasers Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Ophthalmic Lasers Market Research
Mordor Intelligence provides a comprehensive analysis of the ophthalmic lasers market, utilizing our extensive expertise in medical technology research. Our detailed report covers the full range of eye lasers and ophthalmology equipment. This includes advanced technologies such as femtosecond laser systems, photocoagulation laser devices, and ophthalmic YAG laser applications. The analysis explores various aspects of eye surgery laser technologies and ophthalmic surgical equipment, offering insights into both established and emerging treatment modalities.
Stakeholders in the eye treatment laser sector can easily access our report in a downloadable PDF format. It features an in-depth analysis of retinal laser procedures, corneal laser treatments, and eye care laser applications. The report examines key developments in refractive surgery laser technology and provides valuable insights into the femtosecond laser market dynamics. Our research thoroughly covers ocular lasers and their applications, offering strategic intelligence for manufacturers, healthcare providers, and investors in the eye surgery laser market. The comprehensive analysis includes a detailed evaluation of global ophthalmology equipment trends and technological advancements, enabling informed decision-making for industry participants.